Cord blood stem cells may help control type 1 diabetes early on
NCT ID NCT04061746
First seen Apr 26, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study tests whether a single infusion of stem cells from donated umbilical cord blood can safely preserve insulin-making cells in people recently diagnosed with type 1 diabetes. 60 adults aged 18-40 with new-onset diabetes will receive the cells and be monitored for a year. The goal is to slow disease progression and reduce the need for insulin injections, not to cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.